Viewing Study NCT03837210



Ignite Creation Date: 2024-05-06 @ 12:44 PM
Last Modification Date: 2024-10-26 @ 1:03 PM
Study NCT ID: NCT03837210
Status: COMPLETED
Last Update Posted: 2019-02-12
First Post: 2019-02-08

Brief Title: Comparative Anti Helicobacter Pylori Efficacy Assessment of Unani Formulation and Quintuple Regimen
Sponsor: Hamdard University
Organization: Hamdard University

Study Overview

Official Title: Comparative Anti Helicobacter Pylori Efficacy Assessment of Unani Formulation and Quintuple Regimen
Status: COMPLETED
Status Verified Date: 2019-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Helicobacter pylori H pylori is a bacterium its infection is regarded the most common medical condition associated with gastritis1 more over peptic ulcer disease2 gastric adenocarcinoma3 and lymphoma4control of H pylori infection is thought to be the solution of public health problem56 rate of infection is abating in developed world 7 but this is slow and people health is challenged to stop or decrease the new cases is complicated despite the fact that route of transmission are still unclear 8-10 The only option for reducing incidence and prevalence is that screening of masses followed by eradication therapy A rough estimate propose about 50 of developing country population is affected from infection than the industrialized country Infected individual may be asymptomatic or some time present with gastroduodenal disease Prevalence of H pylori is different in developing countries where the adult prevalence reaches up to 80 and in children it is found before the age of 10 years
Detailed Description: Helicobacter pylori H pylori is a bacterium its infection is regarded the most common medical condition associated with gastritis1 more over peptic ulcer disease2 gastric adenocarcinoma3 and lymphoma4control of H pylori infection is thought to be the solution of public health problem56 rate of infection is abating in developed world 7 but this is slow and people health is challenged to stop or decrease the new cases is complicated despite the fact that route of transmission are still unclear 8-10 The only option for reducing incidence and prevalence is that screening of masses followed by eradication therapy A rough estimate propose about 50 of developing country population is affected from infection than the industrialized country Infected individual may be asymptomatic or some time present with gastroduodenal disease Prevalence of H pylori is different in developing countries where the adult prevalence reaches up to 80 and in children it is found before the age of 10 years

Aims and objectives

1 To establish and evaluate scientific and clinical evidence of herbaleastern formulation and find out the clinical safety and efficacy
2 To measure the clinical response of herbal formulation in the patients of HPylori

Research Questions

1 has the Unani formulation better effects than quadruple regimen

Hypothesis H1 Unani has shown better clinical effects than quadruple regimen

Null Hypothesis Ho Quadruple regimen has shown superior clinical response than Unani formulation

Experimental approaches

To check this hypothesis independent variable to dependent variable and perplexing variables will apply by statistical analysis In this study H Pylori infection quadruple regimen are independent variables while signs and symptoms level of improvement are dependent variables

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None